FoRx Therapeutics
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $46.1Mattributed |
|---|---|
| Latest round | series-a, $46.1M, 2025-12-01attributed |
| Founded | 2019 |
| Headquarters | Basel, Switzerland |
| Industry | bio |
| Stage | series-a |
| Website | forxtherapeutics.com |
Biotech company developing PARG inhibitor therapies targeting solid tumours with unmet medical needs
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-12-01 | series-a | $46.1M | undisclosed |
Detected tech stack
WordPress 7.0, Apache HTTP Server, Yoast SEO 27.6, Swiper, jQuery Migrate 3.4.1, Elementor 4.0.9, CookieYes 3.5.0, PHP, MySQL, jquery 3., apache
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $46.1M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $46.1M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | forxtherapeutics.com, read 2026-05-21 |
| Description | self-reported | forxtherapeutics.com, read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.